Metformin attenuates olanzapine-induced hepatic, but not peripheral insulin resistance

The Journal of Endocrinology
Gary RemingtonMargaret Hahn

Abstract

Antipsychotics (APs) are linked to diabetes, even without weight gain. Whether anti-diabetic drugs are efficacious in reversing the direct effects of APs on glucose pathways is largely undetermined. We tested two metformin (Met) doses to prevent impairments seen following a dose of olanzapine (Ola) (3 mg/kg); glucokinetics were measured using the hyperinsulinemic-euglycemic clamp (HIEC). Met (150 mg/kg; n=13, or 400 mg/kg; n=11) or vehicle (Veh) (n=11) was administered through gavage preceding an overnight fast, followed by a second dose prior to the HIEC. Eleven additional animals were gavaged with Veh and received a Veh injection during the HIEC (Veh/Veh); all others received Ola. Basal glucose was similar across treatment groups. The Met 400 group had significantly greater glucose appearance (Ra) in the basal period (i.e., before Ola, or hyperinsulinemia) vs other groups. During hyperinsulinemia, glucose infusion rate (GINF) to maintain euglycemia (reflective of whole-body insulin sensitivity) was higher in Veh/Veh vs other groups. Met 150/Ola animals demonstrated increased GINF relative to Veh/Ola during early time points of the HIEC. Glucose utilization during hyperinsulinemia, relative to basal conditions, was significant...Continue Reading

References

Oct 1, 1993·Annals of Internal Medicine·F X Pi-Sunyer
Apr 3, 2002·Archives of General Psychiatry·John W NewcomerGregg Selke
May 3, 2002·Clinical and Experimental Pharmacology & Physiology·Masami SuzukiHitoshi Ikeda
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Shitij KapurJose N Nobrega
Apr 12, 2003·Diabetes, Obesity & Metabolism·M OttoN Westergaard
Dec 13, 2005·American Heart Journal·Charles H HennekensDaniel E Casey
Dec 14, 2005·Archives of Internal Medicine·Susan M FrayneDan R Berlowitz
Apr 19, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Trino BaptistaLuis Hernández
Jun 15, 2006·The Journal of Nervous and Mental Disease·Julie KreyenbuhlLisa B Dixon
Jun 29, 2006·Clinical Practice and Epidemiology in Mental Health : CP & EMH·M De HertJ Peuskens
Oct 13, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Karen L HouseknechtHans Rollema
Feb 9, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·Carlos T JacksonSusan M Essock
Apr 7, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·Richard W GoldbergLisa B Dixon
May 4, 2007·The Journal of Clinical Investigation·Yan ShuKathleen M Giacomini
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Julia SacherSiegfried Kasper
Jan 8, 2008·Journal of Neuroscience Methods·Nader D HalimJoel E Kleinman
Jan 10, 2008·JAMA : the Journal of the American Medical Association·Ren-Rong WuLe-Hua Li
Jun 27, 2008·Schizophrenia Research·Kirsten LykkegaardLotte Bjerre Knudsen
Sep 17, 2008·Journal of Clinical Psychopharmacology·Araba F ChintohGary Remington
Jan 23, 2009·Schizophrenia Research·Araba F ChintohGary Remington
Nov 10, 2009·Lancet·M De HertR van Winkel
Nov 13, 2009·The Journal of Clinical Endocrinology and Metabolism·Solrun VidarsdottirHanno Pijl
Feb 16, 2010·Metabolism: Clinical and Experimental·David Hauton
Oct 5, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Yana VinogradovaCatherine Penny

❮ Previous
Next ❯

Citations

Jul 15, 2016·The Journal of Endocrinology·E BucrisY Zick
Jan 18, 2018·Scientific Reports·Laura N CastellaniDavid C Wright
Feb 28, 2018·Archives of Physiology and Biochemistry·Baskaran YogalakshmiCarani Venkatraman Anuradha
Oct 5, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hesham ShamshoumDavid C Wright
Jun 3, 2018·Archives of Pharmacal Research·Mou-Ze LiuWei Zhang
Oct 6, 2020·American Journal of Physiology. Endocrinology and Metabolism·Kyle D MedakDavid C Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Karen L HouseknechtHans Rollema
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Margaret K HahnAdria Giacca
© 2021 Meta ULC. All rights reserved